SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001072613-16-000889
Filing Date
2016-08-15
Accepted
2016-08-15 10:50:57
Documents
1
Group Members
ARCH VENTURE PARTNERS VI, L.P.ARCH VENTURE PARTNERS VI, LLCCLINTON BYBEEKEITH CRANDELLROBERT NELSEN

Document Format Files

Seq Description Document Type Size
1 ARCH VENTURE FUND VI, L.P. - SCHEDULE 13DA - AMEND. #2 arch-fate13da2_17974.htm SC 13D/A 197510
  Complete submission text file 0001072613-16-000889.txt   199153
Mailing Address 8755 W HIGGINS RD STE 1025 CHICAGO IL 60631
Business Address 8755 W HIGGINS RD STE 1025 CHICAGO IL 60631 7733806600
ARCH VENTURE FUND VI LP (Filed by) CIK: 0001222135 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A

Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Subject) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D/A | Act: 34 | File No.: 005-87649 | Film No.: 161830728
SIC: 2836 Biological Products, (No Diagnostic Substances)